18:0 PA

Code: 830865P-500MG D2-231

Application

18:0 PA may be used:as a component in the bilayer to study its vesiculation ability on different coat protein I (COPI) fission factorto study its effects on intra...


 Read more

Your Price
€453.42 500MG
€557.71 inc. VAT

Application

18:0 PA may be used:as a component in the bilayer to study its vesiculation ability on different coat protein I (COPI) fission factorto study its effects on intracellular Ca2+concentration ([Ca2+]i) in C6 rat glioma and L2071 mouse fibroblast cells to study its effects on phosphorylation of cytochrome b(558) alpha chain (p22phox)

Biochem/physiol Actions

Phosphatidic acid (PA) acts as a biosynthetic precursorfor the production of membrane glycerophospholipid and triacylglycerol. It participates in the modulation of mammalian target of rapamycin (mTOR) pathway. It may also participate in membrane trafficking, specifically in membrane fusion and fission.

General description

Phosphatidic acid (PA) has two fatty acids and one phosphate group attached to a glycerol backbone. The two fatty acids are present at positionsn-1 andsn-2 of the C-atoms and the phosphate group is present in the sn-3 position of the C-atom.

Packaging

5 mL Amber Glass Screw Cap Vial (830865P-25mg)

20 mL Clear Glass Screw Cap Vial (830865P-500mg)

assay>99% (TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids 830865P
packagingpkg of 1 × 25 mg (830865P-25mg), pkg of 1 × 500 mg (830865P-500mg)
shipped indry ice
storage temp.−20°C
Cas Number108321-18-2
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.